Management of Dermatophilosis in a “7 Year-Old” Friesian Crossbreed Bull
Research in Veterinary Science and Medicine · 2025
DOI: 10.25259/rvsm_11_2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Veterinary Science and Medicine, 2025. Verfasst von Kingsley Chineto Anyika und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
This clinical article reports a case of dermatophilosis in a 7-year-old Friesian and White Fulani cross-breed bull at Livestock Investigation Division of the Veterinary Research Institute, Vom, Nigeria. The following clinical signs were observed; widespread area of dermatitis presenting as dry scabs and crusty nodules. The lesions were mostly present around the dorsum, neck, and shoulders. Skin scrapings were collected and sent to the dermatophilosis laboratory of the National Veterinary Research Institute, Vom for laboratory analysis. The laboratory results confirmed the presence of organisms seen as branching filaments containing multiple rows of cocci, which is characteristic of Dermatophilus congolensis . The infected bull was treated using two doses of long-acting Oxytetracycline at 20 mg/kg, and Lamstreptocide A and B was applied topically twice weekly. The affected animal recovered completely within 90 days of treatment.
Zitieren
APA
Anyika, K. C., Okonkwo, A. R., & Shalangwa, B. I. (2025). Management of Dermatophilosis in a “7 Year-Old” Friesian Crossbreed Bull. Research in Veterinary Science and Medicine. https://doi.org/10.25259/rvsm_11_2024
Vancouver
Anyika KC, Okonkwo AR, Shalangwa BI. Management of Dermatophilosis in a “7 Year-Old” Friesian Crossbreed Bull. Research in Veterinary Science and Medicine. 2025. doi:10.25259/rvsm_11_2024
BibTeX
@article{Anyika2025,
author = {Anyika, Kingsley Chineto and Okonkwo, Amaka Rosita and Shalangwa, Bata Ishaku},
title = {Management of Dermatophilosis in a “7 Year-Old” Friesian Crossbreed Bull},
journal = {Research in Veterinary Science and Medicine},
year = {2025},
doi = {10.25259/rvsm_11_2024}
}
EUVIMED